(3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione

C30H31N5O8S — CID 135109737

IUPAC(3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione
SMILESCOc1ccc2cc1OCC(=O)NCc1ccc(cc1)O[C@H]1CN(S(=O)(=O)c3ccc4c(c3)n(C)c(=O)n4C)C[C@@H]1NC2=O
InChIInChI=1S/C30H31N5O8S/c1-33-23-10-9-21(13-24(23)34(2)30(33)38)44(39,40)35-15-22-27(16-35)43-20-7-4-18(5-8-20)14-31-28(36)17-42-26-12-19(29(37)32-22)6-11-25(26)41-3/h4-13,22,27H,14-17H2,1-3H3,(H,31,36)(H,32,37)/t22-,27-/m0/s1
InChIKeyGDFSKLJCDDQXDZ-CUNXSJBXSA-N
MW621.67 g/mol
LogP1.14
Rot. Bonds3

About (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione

(3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione (PubChem CID 135109737) has the molecular formula C30H31N5O8S and a molecular weight of 621.67 g/mol. Its IUPAC name is (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione.

Molecular Properties

Compound Name(3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione
PubChem CID135109737
Molecular FormulaC30H31N5O8S
Molecular Weight621.67 g/mol
Exact Mass621.19
IUPAC Name(3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione
SMILESCOc1ccc2cc1OCC(=O)NCc1ccc(cc1)O[C@H]1CN(S(=O)(=O)c3ccc4c(c3)n(C)c(=O)n4C)C[C@@H]1NC2=O
InChIInChI=1S/C30H31N5O8S/c1-33-23-10-9-21(13-24(23)34(2)30(33)38)44(39,40)35-15-22-27(16-35)43-20-7-4-18(5-8-20)14-31-28(36)17-42-26-12-19(29(37)32-22)6-11-25(26)41-3/h4-13,22,27H,14-17H2,1-3H3,(H,31,36)(H,32,37)/t22-,27-/m0/s1
InChIKeyGDFSKLJCDDQXDZ-CUNXSJBXSA-N
XLogP1.14
TPSA150.20 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds3
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500621.67
LogP ≤ 51.14
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione?
The IUPAC name of (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione (CID 135109737) is (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione.
What is the SMILES notation for (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione?
The canonical SMILES for (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione is COc1ccc2cc1OCC(=O)NCc1ccc(cc1)O[C@H]1CN(S(=O)(=O)c3ccc4c(c3)n(C)c(=O)n4C)C[C@@H]1NC2=O.
What is the InChIKey of (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione?
The InChIKey is GDFSKLJCDDQXDZ-CUNXSJBXSA-N. The full InChI is InChI=1S/C30H31N5O8S/c1-33-23-10-9-21(13-24(23)34(2)30(33)38)44(39,40)35-15-22-27(16-35)43-20-7-4-18(5-8-20)14-31-28(36)17-42-26-12-19(29(37)32-22)6-11-25(26)41-3/h4-13,22,27H,14-17H2,1-3H3,(H,31,36)(H,32,37)/t22-,27-/m0/s1.
What are the key properties of (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione?
(3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione has a molecular weight of 621.67 g/mol, XLogP of 1.14, 3 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,7S)-5-(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonyl-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione is sourced from PubChem (CID 135109737), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).